1. Home |
  2. Issues |
    3. Medicare Prescription Drug Benefit

PCMA President and CEO Mark Merritt’s Testimony Before the House Oversight and Government Reform Committee

July 24, 2008

PCMA President & CEO Mark Merritt’s Testimony Before the House Oversight and Government Reform Committee on Medicare Part D

^ BACK TO TOP

Tweet

Current Features

Prev Next
It’s the Drugstore Lobby vs. Employers

It’s the Drugstore Lobby vs. Employers »

It's Not the Drugstore's Money

It's Not the Drugstore's Money »

PCMA's Mark Merritt Defends PBMs on CNBC

PCMA's Mark Merritt Defends PBMs on CNBC »

How Mail-Service Pharmacies Will Save $46.6 Billion Over the Next Decade and the Cost of Proposed Restrictions

How Mail-Service Pharmacies Will Save $46.6 Billion Over the Next Decade and the Cost of Proposed Restrictions »

PCMA Launches “That’s What PBMs Do” Ad Campaign

PCMA Launches “That’s What PBMs Do” Ad Campaign »

PBMs Will Save Nearly $2 Trillion in Prescription Drug Costs over the Next Decade

PBMs Will Save Nearly $2 Trillion in Prescription Drug Costs over the Next Decade »

States, Federal Government Could Save $33 Billion by Managing Medicaid Pharmacy More Like Medicare and Commercial Sector Programs

States, Federal Government Could Save $33 Billion by Managing Medicaid Pharmacy More Like Medicare and Commercial Sector Programs »

2012 SPBF Highlights

About PBMs

Connect with PCMA

PCMA · 601 Pennsylvania Avenue NW, Suite 740 South, 20004 · 202-207-3610

© 2010 Pharmaceutical Care Management Association. All rights reserved.